10.23.25 -- Fill/Finish Excellence: Scalable Solutions From Leading CDMOs

Join 1,000+ pharma, biotech, and drug delivery professionals at the PODD: Partnership Opportunities in Drug Delivery Conference conference, October 27–28 in Boston. Featuring 10 technology tracks, pharma company spotlights, 1:1 partnering, and more. Attendees will also hear from leaders at companies including AbbVie, Amgen, AstraZeneca, Biogen, Eli Lilly, GSK, Moderna, Novartis, Pfizer, Regeneron, Roche, Sanofi, Takeda, and others. Register at PODDConference.com with code LSL20 for 20% off.

Geared towards specific biopharmaceutical requirements, the SG EZ-fill® platform includes vials, cartridges, and syringes, sterilized and ready-to-fill, and available in nested and tray configurations.

Discover how Lonza Biologics’ end-to-end Drug Product capabilities support the full lifecycle of biologics, seamlessly integrated with their extensive drug substance network across diverse modalities.

Executive Director of Technology and Business Development for Drug Product and Finished Goods, Henrik Herrmann, shares an update on the current and future state of FDB’s capabilities.

Examine how a new high-speed aseptic filling line can help bring your product to market with speed and efficiency while ensuring safety and high product quality.

See how a cutting-edge, multi-purpose isolator line delivers high-speed, precision fill/finish. This flexible technology supports a diverse range injectable therapies.

Backed by years of dedication to customer-focused solutions, we’re proud to introduce our specialists to the global biopharma community and share insights that drive innovation forward.

We are committed to the highest quality standards, offering end-to-end manufacturing solutions in Mammalian, Microbial, Cell and Gene Therapy, xRNA, Small Molecules, and Fill/Finish.

Performing transfers from small-scale development processes to full-scale commercial manufacturing can be difficult, but the wrong CMO partner can pose its own challenges.